Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 14/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.40 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.36 |
| ▸ | GSR | P00390 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38735 | 0.72 | GRIK1 (0.68) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL2730539 | 0.72 | GRIK1 (0.68) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL5967305 | 0.72 | GRIK1 (0.68) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL10017793 | 0.71 | DPP7 (0.46) | NOD1GSR | |
| SCHEMBL19966782 | 0.71 | DPP7 (0.46) | NOD1GSR | |
| SCHEMBL1527353 | 0.71 | GRIK1 (0.69) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL1960915 | 0.71 | GRIK1 (0.69) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL5048329 | 0.71 | GRIK1 (0.69) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL1738925 | 0.71 | GRIK1 (0.69) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL3689310 | 0.71 | GRIK1 (0.69) | NOD1GRIK1GRIK2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697383-A | Methods of treating viral infections and health problems | 艾伦·戴维多夫 | 2023-02-03 | — | — | CN | disclosed |